Dissolution-Enhancing Mechanism of Alkalizers in Poloxamer-Based Solid Dispersions and Physical Mixtures Containing Poorly Water-Soluble Valsartan

被引:32
作者
Nam Sung Ha [1 ]
Thao Truong-Dinh Tran [1 ]
Phuong Ha-Lien Tran [1 ]
Park, Jun-Bom [1 ]
Lee, Beom-Jin [1 ]
机构
[1] Kangwon Natl Univ, Bioavailabil Control Lab, Coll Pharm, Chunchon 200701, South Korea
关键词
valsartan; alkalizer; solid dispersion; structural change; drug dissolution; microenvironmental pH; MICROENVIRONMENTAL PH; ORAL BIOAVAILABILITY; DRUG; ENHANCEMENT; SOLUBILITY; SULFATHIAZOLE; INDOMETHACIN; ITRACONAZOLE; NIFEDIPINE; RELEASE;
D O I
10.1248/cpb.59.844
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The purpose of this study was to investigate the effects of alkalizers in dissolution rate and crystal structure of valsartan (VAL) in Poloxamer 407 (PDX)-based solid dispersions (SD). VAL, a poorly-water soluble drug was selected as a model drug because of its low solubility at low pH. The PDX-based SDs containing alkalizers (Na2CO3, MgO, meglumine and arginine) were prepared by melting method. The dissolution tests were performed using the United States Pharmacopeia (USP) paddle 11 method in enzyme-free simulated gastric fluid (pH 1.2) for 2 h. Microenvironmental pH (pH(M)) was examined potentiometrically by using a surface pH electrode. Dissolution rate of SD incorporating Na2CO3 was drastically increased. The differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) data indicated that crystalline structure of VAL in SD was transformed to amorphous form by the addition of alkalizers but could not explain the differences in the dissolution rates. The molecular interaction between VAL and Na2CO3 was observed in the Fourier transform infrared spectroscopy (FT-IR) spectra by the shift of C=O band from 1732 to 1719 cm(-1) and the disappearance of carbonyl group at 1598 cm(-1). Furthermore, Na2CO3 efficiently modulated pH(M) by providing a favorable microenvironment for drug dissolution. A combination of SD method and use of alkalizer is a promising approach to modulate release rate of poorly water-soluble and ionizable drug with an aid of changes of drug crystallinity, molecular interaction and pH(M).
引用
收藏
页码:844 / 850
页数:7
相关论文
共 35 条
  • [1] Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers
    Ahuja, Naveen
    Katare, Om Prakash
    Singh, Bhupinder
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 65 (01) : 26 - 38
  • [2] pKa determination of angiotensin II receptor antagonists (ARA II) by spectrofluorimetry
    Cagigal, E
    González, L
    Alonso, RM
    Jiménez, RM
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2001, 26 (03) : 477 - 486
  • [3] Improvement of solubility and stability of valsartan by hydroxypropyl-β-cyclodextrin
    Cappello, Brunella
    Di Maio, Clelia
    Iervolino, Maria
    Miro, Agnese
    [J]. JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY, 2006, 54 (3-4) : 289 - 294
  • [4] PHASE DIAGRAM AND DISSOLUTION-RATE STUDIES ON SULFATHIAZOLE-UREA SOLID DISPERSIONS
    CHIOU, WL
    NIAZI, S
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) : 1333 - &
  • [5] Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions
    Chutimaworapan, S
    Ritthidej, GC
    Yonemochi, E
    Oguchi, T
    Yamamoto, K
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (11) : 1141 - 1150
  • [6] MICROENVIRONMENTAL PH CONTROL OF DRUG DISSOLUTION
    DOHERTY, C
    YORK, P
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1989, 50 (03) : 223 - 232
  • [7] A review of poloxamer 407 pharmaceutical and pharmacological characteristics
    Dumortier, Gilles
    Grossiord, Jean Louis
    Agnely, Florence
    Chaumeil, Jean Claude
    [J]. PHARMACEUTICAL RESEARCH, 2006, 23 (12) : 2709 - 2728
  • [8] Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man
    Flesch, G
    Muller, P
    Lloyd, P
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (02) : 115 - 120
  • [9] FORD JL, 1986, PHARM ACTA HELV, V61, P69
  • [10] Enhanced solubility and dissolution rate of itraconazole by a solid dispersion technique
    Jung, JY
    Yoo, SD
    Lee, SH
    Kim, KH
    Yoon, DS
    Lee, KH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 187 (02) : 209 - 218